markets · · seekingalpha.com
Privia Health Group: Operating Leverage Could Lead To Share Price Upside
Privia Health Group is rated BUY, supported by strong operating leverage and expanding value-based care, positioning for earnings upside. PRVA trades at a 48% discount to its five-year average forward EV/EBITDA, with 24% forward EBITDA growth, outpacing peers. 2Q26 results showed 15% care margin growth, 29% adjusted EBITDA growth, and robust provider and patient expansion, highlighting operating efficiency.
Privia Health Group is rated BUY, supported by strong operating leverage and expanding value-based care, positioning for earnings upside. PRVA trades at a 48% discount to its five-year average forward EV/EBITDA, with 24% forward EBITDA growth, outpacing peers. 2Q26 results showed 15% care margin growth, 29% adjusted EBITDA growth, and robust provider and patient expansion, highlighting operating efficiency.
- #PRVA